Faith Mutale

1.1k total citations · 1 hit paper
10 papers, 811 citations indexed

About

Faith Mutale is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Faith Mutale has authored 10 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Faith Mutale's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Faith Mutale is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Faith Mutale collaborates with scholars based in United States. Faith Mutale's co-authors include Corey J. Langer, Evan Alley, Christine Ciunci, Charu Aggarwal, Tracey L. Evans, Joshua Bauml, Roger B. Cohen, Patricia G. Archbold, Karen Schumacher and Barbara J. Stewart and has published in prestigious journals such as Journal of Thoracic Oncology, JAMA Oncology and Lung Cancer.

In The Last Decade

Faith Mutale

10 papers receiving 797 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

2017 387 citations Stephen Bagley, Shawn Kothari et al. Lung Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Faith Mutale United States	6	578	325	110	86	77	10	811
Annelies Janssens Belgium	18	360 0.6×	333 1.0×	40 0.4×	87 1.0×	28 0.4×	62	767
Paul Blood Canada	13	248 0.4×	278 0.9×	77 0.7×	128 1.5×	23 0.3×	34	679
Clarissa Mathias Brazil	10	409 0.7×	154 0.5×	147 1.3×	65 0.8×	9 0.1×	32	749
Jorge Riera Knorrenschild Germany	12	282 0.5×	331 1.0×	49 0.4×	207 2.4×	18 0.2×	44	700
Nasrin Fouladi Iran	11	192 0.3×	103 0.3×	45 0.4×	69 0.8×	42 0.5×	23	457
Nita K. Lee United States	14	279 0.5×	106 0.3×	63 0.6×	153 1.8×	15 0.2×	39	1.1k
Mohamad Farid Singapore	13	323 0.6×	277 0.9×	36 0.3×	77 0.9×	50 0.6×	80	624
Po‐Jung Su Taiwan	14	239 0.4×	83 0.3×	106 1.0×	105 1.2×	39 0.5×	47	534
Thomas F. Rocereto United States	13	283 0.5×	178 0.5×	49 0.4×	334 3.9×	62 0.8×	21	1.2k
Fadi El Karak Lebanon	13	225 0.4×	155 0.5×	34 0.3×	78 0.9×	20 0.3×	51	462

Countries citing papers authored by Faith Mutale

Since Specialization

Citations

This map shows the geographic impact of Faith Mutale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faith Mutale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faith Mutale more than expected).

Fields of papers citing papers by Faith Mutale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faith Mutale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faith Mutale. The network helps show where Faith Mutale may publish in the future.

Co-authorship network of co-authors of Faith Mutale

This figure shows the co-authorship network connecting the top 25 collaborators of Faith Mutale. A scholar is included among the top collaborators of Faith Mutale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faith Mutale. Faith Mutale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Bauml, Joshua, Rosemarie Mick, Christine Ciunci, et al.. (2019). Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer. JAMA Oncology. 5(9). 1283–1283. 217 indexed citations

2.

Ciunci, Christine, Charu Aggarwal, Christiana Davis, et al.. (2018). OA07.01 Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT). Journal of Thoracic Oncology. 13(10). S335–S336. 2 indexed citations

3.

Kothari, Shawn, Stephen Bagley, Charu Aggarwal, et al.. (2017). P3.02c-029 Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab. Journal of Thoracic Oncology. 12(1). S1290–S1290. 9 indexed citations

4.

Bagley, Stephen, Shawn Kothari, Charu Aggarwal, et al.. (2017). P3.02c-028 Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S1289–S1289. 4 indexed citations

5.

Bagley, Stephen, Shawn Kothari, Charu Aggarwal, et al.. (2017). Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer. 106. 1–7. 387 indexed citations breakdown →

6.

Bagley, Stephen, Shawn Kothari, Charu Aggarwal, et al.. (2017). P3.02c-069 Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Outcomes with Nivolumab in Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S1318–S1318. 2 indexed citations

7.

Bauml, Joshua, Rosemarie Mick, Christine Ciunci, et al.. (2017). OA 17.08 Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT). Journal of Thoracic Oncology. 12(11). S1794–S1795. 2 indexed citations

8.

Bauman, Jessica R., Corey J. Langer, Harry Quon, et al.. (2013). Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck. Experimental and Therapeutic Medicine. 5(4). 1247–1253. 22 indexed citations

9.

Chawla, Sanjeev, Sungheon Kim, Laurie A. Loevner, et al.. (2009). Proton and Phosphorous MR Spectroscopy in Squamous Cell Carcinomas of the Head and Neck. Academic Radiology. 16(11). 1366–1372. 17 indexed citations

10.

Schumacher, Karen, et al.. (2008). Effects of Caregiving Demand, Mutuality, and Preparedness on Family Caregiver Outcomes During Cancer Treatment. Oncology nursing forum. 35(1). 49–56. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact